These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8843637

  • 1. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan.
    Apostolopoulos V, Pietersz GA, McKenzie IF.
    Vaccine; 1996 Jun; 14(9):930-8. PubMed ID: 8843637
    [Abstract] [Full Text] [Related]

  • 2. Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice.
    Lees CJ, Apostolopoulos V, Acres B, Ramshaw I, Ramsay A, Ong CS, McKenzie IF.
    Vaccine; 2000 Sep 15; 19(2-3):158-62. PubMed ID: 10930667
    [Abstract] [Full Text] [Related]

  • 3. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.
    Apostolopoulos V, Xing PX, McKenzie IF.
    Cancer Res; 1994 Oct 01; 54(19):5186-93. PubMed ID: 7923138
    [Abstract] [Full Text] [Related]

  • 4. The immune response of mice and cynomolgus monkeys to macaque mucin 1-mannan.
    Vaughan HA, Ho DW, Karanikas V, Sandrin MS, McKenzie IF, Pietersz GA.
    Vaccine; 2000 Aug 01; 18(28):3297-309. PubMed ID: 10869775
    [Abstract] [Full Text] [Related]

  • 5. Induction of humoral and cellular responses in cynomolgus monkeys immunised with mannan-human MUC1 conjugates.
    Vaughan HA, Ho DW, Karanikas VA, Ong CS, Hwang LA, Pearson JM, McKenzie IF, Pietersz GA.
    Vaccine; 1999 Jun 04; 17(20-21):2740-52. PubMed ID: 10418926
    [Abstract] [Full Text] [Related]

  • 6. Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.
    Apostolopoulos V, Pietersz GA, Loveland BE, Sandrin MS, McKenzie IF.
    Proc Natl Acad Sci U S A; 1995 Oct 24; 92(22):10128-32. PubMed ID: 7479739
    [Abstract] [Full Text] [Related]

  • 7. Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection.
    Karanikas V, Thynne G, Mitchell P, Ong CS, Gunawardana D, Blum R, Pearson J, Lodding J, Pietersz G, Broadbent R, Tait B, McKenzie IF.
    J Immunother; 2001 Oct 24; 24(2):172-83. PubMed ID: 11265775
    [Abstract] [Full Text] [Related]

  • 8. Induction of T1 (cytotoxic lymphocyte) and/or T2 (antibody) responses to a mucin-1 tumour antigen.
    Lofthouse SA, Apostolopoulos V, Pietersz GA, Li W, McKenzie IF.
    Vaccine; 1997 Oct 24; 15(14):1586-93. PubMed ID: 9330472
    [Abstract] [Full Text] [Related]

  • 9. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.
    Karanikas V, Hwang LA, Pearson J, Ong CS, Apostolopoulos V, Vaughan H, Xing PX, Jamieson G, Pietersz G, Tait B, Broadbent R, Thynne G, McKenzie IF.
    J Clin Invest; 1997 Dec 01; 100(11):2783-92. PubMed ID: 9389743
    [Abstract] [Full Text] [Related]

  • 10. Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1.
    Pietersz GA, Li W, Osinski C, Apostolopoulos V, McKenzie IF.
    Vaccine; 2000 Apr 03; 18(19):2059-71. PubMed ID: 10706970
    [Abstract] [Full Text] [Related]

  • 11. Cyclophosphamide enhances the CTL precursor frequency in mice immunized with MUC1-mannan fusion protein (M-FP).
    Apostolopoulos V, Popovski V, McKenzie IF.
    J Immunother; 1998 Mar 03; 21(2):109-13. PubMed ID: 9551361
    [Abstract] [Full Text] [Related]

  • 12. The immunogenicity of MUC1 peptides and fusion protein.
    Apostolopoulos V, Pietersz GA, Xing PX, Lees CJ, Michael M, Bishop J, McKenzie IF.
    Cancer Lett; 1995 Mar 23; 90(1):21-6. PubMed ID: 7720038
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CTL in mice immunized with human mucin 1 are MHC-restricted.
    Apostolopoulos V, Loveland BE, Pietersz GA, McKenzie IF.
    J Immunol; 1995 Dec 01; 155(11):5089-94. PubMed ID: 7594517
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls.
    Snijdewint FG, von Mensdorff-Pouilly S, Karuntu-Wanamarta AH, Verstraeten AA, van Zanten-Przybysz I, Hummel P, Nijman HW, Kenemans P, Hilgers J.
    Cancer Immunol Immunother; 1999 Apr 01; 48(1):47-55. PubMed ID: 10235488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.